Skip to main content
. 2022 Jun;13(3):1330–1339. doi: 10.21037/jgo-22-478

Figure 3.

Figure 3

Subgroup analysis revealed that there was no significant difference in (A) OS and (B) RFS among the insulin group, metformin group, insulin plus metformin group, and other drugs group (P=0.412 for OS and P=0.934 for RFS). OS, overall survival; RFS, recurrence-free survival.